341 related articles for article (PubMed ID: 21323689)
21. Methotrexate in inflammatory bowel disease.
Feagan BG; Alfadhli A
Gastroenterol Clin North Am; 2004 Jun; 33(2):407-20, xi. PubMed ID: 15177546
[TBL] [Abstract][Full Text] [Related]
22. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Lichtenstein GR; Abreu MT; Cohen R; Tremaine W;
Gastroenterology; 2006 Mar; 130(3):940-87. PubMed ID: 16530532
[No Abstract] [Full Text] [Related]
23. [Current medical treatment of inflammatory bowel disease].
Bosques-Padilla F
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
[No Abstract] [Full Text] [Related]
24. Inflammatory bowel disease: management issues during pregnancy.
Ferrero S; Ragni N
Arch Gynecol Obstet; 2004 Sep; 270(2):79-85. PubMed ID: 12721680
[TBL] [Abstract][Full Text] [Related]
25. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
26. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
27. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
[TBL] [Abstract][Full Text] [Related]
28. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
Dignass A; Van Assche G; Lindsay JO; Lémann M; Söderholm J; Colombel JF; Danese S; D'Hoore A; Gassull M; Gomollón F; Hommes DW; Michetti P; O'Morain C; Oresland T; Windsor A; Stange EF; Travis SP;
J Crohns Colitis; 2010 Feb; 4(1):28-62. PubMed ID: 21122489
[No Abstract] [Full Text] [Related]
29. [Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
Stange EF
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S90-S1. PubMed ID: 11930299
[TBL] [Abstract][Full Text] [Related]
30. Position statement: immunomodulator therapy for inflammatory Bowel disease.
Lavy A; Chowers Y; Odes HS; Eliakim R;
Isr Med Assoc J; 2003 Mar; 5(3):164-9. PubMed ID: 12725133
[No Abstract] [Full Text] [Related]
31. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
Lichtenstein GR; Sbreu MT; Cohen R; Tremaine W
Rev Gastroenterol Mex; 2006; 71(3):351-401. PubMed ID: 17140062
[No Abstract] [Full Text] [Related]
32. Treatment of sarcoidosis.
King CS; Kelly W
Dis Mon; 2009 Nov; 55(11):704-18. PubMed ID: 19857644
[No Abstract] [Full Text] [Related]
33. Pharmacogenetics and inflammatory bowel disease: progress and prospects.
Ho GT; Lees C; Satsangi J
Inflamm Bowel Dis; 2004 Mar; 10(2):148-58. PubMed ID: 15168816
[No Abstract] [Full Text] [Related]
34. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
35. [Chronic inflammatory bowel diseases. Immunosuppressive drug saves on corticoids].
MMW Fortschr Med; 1999 Sep; 141(38):55. PubMed ID: 10904620
[No Abstract] [Full Text] [Related]
36. Improvement of anti-TNFα antibody-induced pustular psoriasis by azathioprine.
Kayama T; Otsuka A; Miyachi Y; Kabashima K
Eur J Dermatol; 2012; 22(4):565-6. PubMed ID: 22853939
[No Abstract] [Full Text] [Related]
37. Medical therapies for inflammatory bowel disease.
Stotland BR; Cirigliano MD; Lichtenstein GR
Hosp Pract (1995); 1998 May; 33(5):141-4, 149-51, 156 passim. PubMed ID: 9606359
[TBL] [Abstract][Full Text] [Related]
38. Practical guidelines for the treatment of inflammatory bowel disease.
Kuhbacher T; Fölsch UR
World J Gastroenterol; 2007 Feb; 13(8):1149-55. PubMed ID: 17451192
[TBL] [Abstract][Full Text] [Related]
39. Azathioprine-Associated Complete NK Cell Deficiency.
Orandi AB; Vogel TP; Keppel MP; Utterson EC; Cooper MA
J Clin Immunol; 2017 Aug; 37(6):514-516. PubMed ID: 28639167
[No Abstract] [Full Text] [Related]
40. Tumor necrosis factor inhibitors for inflammatory bowel disease.
Nielsen OH; Ainsworth MA
N Engl J Med; 2013 Aug; 369(8):754-62. PubMed ID: 23964937
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
